Reports for HYDROCHLOROTHIAZIDE
Ingredient
HYDROCHLOROTHIAZIDE
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ALTACE HCT | 12.5MG 5MG | TABLET | Resolved | 2018-09-27 | 2019-03-06 | 62498 |
| ALTACE HCT | 12.5MG 5MG | TABLET | Resolved | 2020-02-14 | 2020-05-13 | 106255 |
| ALTACE HCT | 5MG 12.5MG | TABLET | Resolved | 2020-10-28 | 2020-11-02 | 127447 |
| ALTACE HCT | 12.5MG 10.0MG | TABLET | Resolved | 2017-08-17 | 2017-11-22 | 19733 |
| ALTACE HCT | 12.5MG 10.0MG | TABLET | Resolved | 2017-12-08 | 2018-05-11 | 32249 |
| ALTACE HCT | 12.5MG 10.0MG | TABLET | Resolved | 2018-01-23 | 2018-05-04 | 36998 |
| ALTACE HCT | 12.5MG 10.0MG | TABLET | Resolved | 2020-03-05 | 2020-05-13 | 107810 |
| ALTACE HCT | 12.5MG 2.5MG | TABLET | Resolved | 2017-08-17 | 2018-05-16 | 19736 |
| ALTACE HCT | 2.5MG 12.5MG | TABLET | Resolved | 2020-05-13 | 2020-11-02 | 114951 |
| ALTACE HCT | 25.0MG 5.0MG | TABLET | Resolved | 2017-05-26 | 2017-09-02 | 11351 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255830 |
| TEVA-VALSARTAN/HCTZ | 25MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255833 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256140 |
| TEVA-VALSARTAN/HCTZ | 25MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256143 |
| TEVETEN PLUS | 12.5MG 600MG | TABLET | Discontinued | 2024-12-10 | 2024-12-10 | 245261 |
| VALSARTAN HCT | 25MG 320MG | TABLET | Discontinued | 2019-09-18 | 2020-01-09 | 94211 |